Although our patients’ cohort was small and heterogonous, it allowed us to hypothesize that a decreased TSPAN14 expression could be a candidate indicating invasiveness and poor prognosis of NSCLC. Here, TSPAN14 is linked to non-small cell lung carcinoma.